Racial disparity in pathophysiologic pathways of preterm birth based on genetic variants
© Menon et al; licensee BioMed Central Ltd. 2009
Received: 11 May 2009
Accepted: 15 June 2009
Published: 15 June 2009
To study pathophysiologic pathways in spontaneous preterm birth and possibly the racial disparity associating with maternal and fetal genetic variations, using bioinformatics tools.
A large scale candidate gene association study was performed on 1442 SNPs in 130 genes in a case (preterm birth < 36 weeks) control study (term birth > 37 weeks). Both maternal and fetal DNA from Caucasians (172 cases and 198 controls) and 279 African-Americans (82 cases and 197 controls) were used. A single locus association (genotypic) analysis followed by hierarchical clustering was performed, where clustering was based on p values for significant associations within each race. Using Ingenuity Pathway Analysis (IPA) software, known pathophysiologic pathways in both races were determined.
From all SNPs entered into the analysis, the IPA mapped genes to specific disease functions. Gene variants in Caucasians were implicated in disease functions shared with other known disorders; specifically, dermatopathy, inflammation, and hematological disorders. This may reflect abnormal cervical ripening and decidual hemorrhage. In African-Americans inflammatory pathways were the most prevalent. In Caucasians, maternal gene variants showed the most prominent role in disease functions, whereas in African Americans it was fetal variants. The IPA software was used to generate molecular interaction maps that differed between races and also between maternal and fetal genetic variants.
Differences at the genetic level revealed distinct disease functions and operational pathways in African Americans and Caucasians in spontaneous preterm birth. Differences in maternal and fetal contributions in pregnancy outcome are also different between African Americans and Caucasians. These results present a set of explicit testable hypotheses regarding genetic associations with preterm birth in African Americans and Caucasians
Preterm birth (< 37 weeks of gestation) rates vary considerably between racial groups in the United States. The rate is 18.4% in non-Hispanic African-Americans and 11.7% in non-Hispanic Caucasians in 2005 . The African American population has a disproportionate burden of several adverse socioeconomic and environmental factors that have an indisputable connection with PTB . Nevertheless, racial differences in preterm birth cannot be fully explained based on behavioral, psycho-social, or socioeconomic factors [3–5]. Moreover, there are numerous examples in the scientific literature in which racial disparity in disease prevalence is closely associated with genetic variation , and genes that regulate immune and hematological functions are over-represented among these, presumably reflecting adaptation of ancestral populations to geographically-restricted pathogens .
Understanding spontaneous preterm birth is difficult due to etiologic and pathophysiologic heterogeneities and racial disparity can further complicates this. Etiologic factors such as infection, stress, placental abruption, uterine distension, and preterm premature rupture of membranes, among others are associated with preterm birth in both races. Redundancy of biochemical pathways and biomarkers of preterm birth regardless of etiology suggests pathophysiologic heterogeneity. One explanation for racial disparity may be genetic variations (polymorphisms) that differ in frequency between races or that provide a different genetic context for particular polymorphisms to function. A review of the literature suggests emerging evidence for gene-gene interactions (epistasis) and gene-environment interactions in preterm birth [8–10], some of which may affect African Americans and Caucasians differently . Candidate gene studies of preterm birth indicate greater than expected (60–80% observed for PTB candidate genes vs. ~42% average across the genome allele and genotype single nucleotide polymorphisms (SNPs) frequencies differences between African-Americans and Caucasians [12, 13]. In the context of gene-gene and gene-environment interactions that are becoming increasingly apparent, these differences can affect the ability to detect both single SNP associations and critical pathways between populations, indicating that genetic architectures in the two groups may affect pregnancy outcome [14, 15].
In addition to static genetic markers, dynamic biomarkers in amniotic fluid and fetal membranes also reveal significant racial disparity, such as inflammatory marker expression and their concentrations in preterm birth [16, 17]. Studies suggest that biomarkers thought to be indicators of preterm birth may not be generalizable. Therefore, a simplified, uniform approach to risk identification and common intervention may not be adequate because of different etiological factors that involve many biomolecular factors. Furthermore, preterm birth can be a function of both maternal and fetal risk factors and their interactions at the genetic and biomarker level making the clinical outcome exceedingly complex.
Based on the evidence generated in our laboratory on genetic (both maternal and fetal) and biomarker data from African-Americans and Caucasians [11–17], we hypothesize that genetic predispositions in preterm birth pathway genes differentially affect biomolecular events in each race and this may explain some of the racial disparity. To assess this, genotyping data generated from a large scale candidate gene study were subjected to pathway analyses, using bioinformatics tools [18, 19]. Since genes operate within biological networks, we used the Ingenuity Systems Pathways Analysis Software and Knowledge Base (IPA) to estimate whether the pattern of preterm birth candidate genes points to particular biomolecular networks or disease mechanism(s) in African Americans and Caucasians.
This study was approved by the institutional review board at TriStar, the parent company institutional review board of record for Centennial Women's Hospital, Nashville, Tennessee (USA).
Genetic analysis performed on a case control study was used for this report. Mothers between the ages of 18 and 40 were recruited. Gestational age was determined by last menstrual period and corroborated by ultrasound dating. Cases (spontaneous preterm birth) were defined as presence of regular uterine contractions at < 360/7 weeks gestation (2 contractions/10 minutes with documented cervical changes) followed by delivery. Cases and controls were selected from a Nashville cohort between September 2003 and December 2006. Subjects presented with preterm or term labor were given an opportunity to consent for the study when they matched our inclusion criteria. Subjects with medically indicated preterm births such as multiple gestations, preeclampsia, preterm premature rupture of the membranes, placental previa, infant anomalies, gestational diabetes, poly- and oligohydramnios, and other complications such as surgeries during pregnancies were excluded [11–17]. Controls consisted of women having normal labor and delivery at term (≥ 370/7 weeks) with no medical or obstetrical complications during pregnancy.
Race was identified by self-report and a questionnaire that traces ethnicity back two generations from the parents [11–17]. Individuals who had more than one racial group in their ancestry were excluded from the study [18–20]. African Americans and Caucasians of non-Hispanic origin was included in this study.
High-throughput candidate gene association studies were performed on 370 maternal (172 cases and 198 controls) and 319 fetal (140 cases and 179 controls) DNA samples from Caucasians and 279 maternal (82 cases and 197 controls) and 243 fetal (65 case and 183 control) samples from African-Americans. The candidate genes are listed in our earlier publications [16, 17]. A total of 1536 tag SNPs were screened in 130 preterm birth candidate genes. Genotyping was performed by Illumina's GoldenGate genotyping system . We compared African American cases to Caucasian cases, African-American controls to Caucasian controls for both maternal and fetal DNA.
Statistical tests for differences between case and control and African-American and Caucasian allele and genotype frequencies, measurements of allele frequencies and tests deviations from Hardy Weinberg Equilibrium (HWE) were calculated by the use of Powermarker statistical software . Statistical significance for all single locus tests of association and tests for the deviation from HWE were performed with Fishers Exact tests. Clinical and demographic characteristics between cases and controls were compared using Shapiro-Wilks tests of normality on gravidity, gestational age, gestational weight, APGAR 1, and APGAR 5. All measurements deviated significantly from normality; as a result Mann-Whitney two-sample rank sum tests were used to compare case and control groups. Standard t-tests were used to test whether maternal age differed between cases and controls. χ2 or Fisher's exact tests were used to test for differences in the counts of smokers and non-smokers, income differences, and insurance differences between cases and controls. STATA 9.0 statistical software was used for all analyses of clinical and demographic data and an uncorrected p value ≤ 0.05 was considered significant.
Ingenuity systems pathway analysis (IPA) and knowledgebase for pathway identification
To examine whether the SNPs found to be putatively-associated with preterm birth in each race mapped to different biological networks and disease functions, we used IPA [23–26]. The gene variants that were statistically significantly-associated with preterm birth (p ≤ 0.05) for each race were entered into the IPA analysis tool. These genes were termed "focus genes." The IPA software was used to measure associations of these molecules with other molecules and disease functions stored in its knowledgebase. The knowledgebase encompasses relationships between proteins, genes, cells, tissues, xenobiotics, and diseases. The information is scientist-curated, updated, and integrated from the published literature and other databases such as OMIM, Gene Ontology, and KEGG.
Disease function categories are among the biological functional ontologies developed by experts across broad domains of biology at IPA. There are 27 higher-order disease and disorder categories in the IPA knowledgebase, and below these higher order categories, there are lower level and specific functions. The IPA functional annotations have integrated GO data , but the IPA knowledgebase is more extensive and complete, and therefore uses a different but overlapping terminology. Enrichment of focus genes in higher order disease categories were evaluated by comparing p-values calculated by the IPA software. The p-value for a given function is calculated by considering: 1) the number of identified focus molecules from the user input that participate in that disease and disorder function and, 2) the total number of molecules that are known to be associated with that function in the IPA knowledge base. To derive p-values, the IPA software uses a right-tailed Fisher Exact Tests calculate likelihood that the association between the set of focus genes and a disease function is due to random chance. If a higher-order disease and disorder category contains two or more specific functions reaching statistical significance, the software displays the most statistically significant value on the y axis of the bar graph.
We used the IPA software to identify new molecular network(s) that involve our focus genes. By drawing on its knowledgebase, the IPA software models cellular and molecular networks, including, binding, phosphorylation, proteolysis, nuclear receptor activation, gene transcription, and sub-cellular localization. We mapped focus genes to networks based on their mechanistic associations with each other and partner molecules. The IPA statistical algorithm identifies molecular pathways, involving these focus genes based on their selective interconnectivity with each other and additional molecules stored in the genome-scale knowledgebase. These networks are illustrated and ranked by the software for significance of focus gene enrichment.
Differences between genotypic frequencies between African Americans and Caucasians
% Genotype frequency difference
% Genotype frequency difference
Because the patterns of genetic association and therefore the detectable network patterns can be affected by differences in genotype and allele frequencies, it is important to assess the differences between our African-Americans and Caucasians prior to IPA analysis. After removing monomorphic markers and those with low genotyping efficiency from 1536 SNPs, 1442 remained for this analysis. Overall, the results indicate that the vast majority of SNPs assayed differed between African-Americans and Caucasians in genotype frequencies (~68–80%), and that controls appeared to be slightly more different than cases (Table 1). Of note, the vast majority of differences observed were highly significant. The proportion of comparisons with genotype frequency differences more significant than p = 0.001, range from 935 of 1442 SNPs in maternal controls to 668 of 1442 SNPs in fetal cases. These data demonstrate that the African-Americans and Caucasians were highly different in terms of the distribution of genetic variation at the candidate loci we studied. In addition, these proportions exceed the average across genome differences expected between Africans and Caucasians in the Hap Map data (average ~55% [data not shown]).
Within the IPA disease ontology tree, the disease-related function contributing most to the significance was also of interest. For example, under hematological diseases, processes related to apoptosis and cell death were more significant in African-American mothers (p = 5.56E-12 to 8.11E-11) than in Caucasian mothers (1.07E-7 to 1.90 E-4). Conversely, hematological "disorders", thrombosis, and hemorrhage (also subsumed under hematological "diseases") were significant in Caucasian mothers (p-values 1.09E-6 to 1.73E-4) but did not reach significance in African American mothers.
Disease functions as detected by IPA based on significant genetic variations in maternal and fetal candidate genes in Caucasians and its interpretation in spontaneous preterm birth.
Disease functions as detected by IPA
Genes involved in determining the disease functions
Potential pathophysiological role in preterm birth
Dermatologic disease and conditions
COL1A1, COL3A1, COL5A1, COL5A2, CTLA4, CYP19A1, IL5, IL10, IL18, MMP3, MMP1, NFKBIA, PLAT, PTGS1, TLR2, TLR7, TNFR1, TNFR2,
COL1A2, COL3A1, COL5A2, CYP19A1, IGF1, IL5, IL1A, IL1B, IL1RN, IL4R, MMP, NFKBIA, PGR, PTGS2, TLR7
Because dermatological disorders typically involve combined collagen remodeling aided by inflammation and, this function appears to reflect premature cervical ripening and membrane weakening related to preterm birth. Collagenolysis may involve an underlying inflammatory process as suggested by cytokines, cytokine receptors, cytokine signaling pathway genes that is likely a secondary event.
Etiology → Collagenolysis → inflammation → Premature cervical ripening and membrane weakening → Preterm birth.
CCL2, CTLA4, CYP19A1, F7, IL5, IL10, IL18, IL1R1, MMP3, MMP1, NFKBIA, PLA2G4A, PLAT, PTGER3, PTGS1, TIMP3, TLR2, TNFR1, TNFR2
CRHR2, CYP19A1, IGF1, IL5, IL10RA, IL1A, IL1B, IL1RN, IL2RB, IL4R, KL, MMP8, MMP1, NFKBIA, PGR, PTGS2, TIMP3, TREM1
Underlying inflammatory conditions associated with preterm birth (see above)
CCL2, CTLA4, CYP19A1, F5, F7, HSD11B1, IL5, IL10, IL18, IL1RAP, NFKBIA, PLA2G4A, PLAT, PTGS1, TLR2, TNFR1, TNFR2
CBS, IGF1, IL5, IL1A, IL1B, IL1RAP, IL1RN, IL2RB, IL4R, MMP8, NFKBIA, NFKBIE, PGR, PTGS2
Involvement of genes in the hematological pathway indicates decidual hemorrhage and associated problems associated with Caucasian preterm birth.
Disease functions as detected by IPA based on significant genetic variations in maternal and fetal candidate genes in African Americans and its interpretation in spontaneous preterm birth.
Disease functions as detected by IPA
Genes involved in determining the disease functions
Potential pathophysiological role in preterm birth
ACE, CCL2, CTLA4, IFNG, IL4, IL15, IL10RA, IL1B, IL1R1, IL2RA, IL2RB, IL4R, IL6R, KL, MMP2, MMP8, NFKB1, NOD2, NR3C1, POMC, PTGER3, SLC6A4, TIMP3, TNFR1, TNFR2, VEGFA
CD14, CTLA4, IFNG, IL2, IL6, IL8, IL10, IL15, IL10RB, IL1R1, IL1RN, IL2RB, MMP2, MMP3, MMP8, MMP9, NFKB1, NFKBIB, NOD2, PTGER3, TIMP3, TLR4, TNF, TNFR1, TNFR2, TREM1
Overwhelming inflammation appears to be the primary effecter of preterm birth in African Americans regardless of etiology. Fetal response is dominant (see Figure 2) along with complementary maternal contributions. This combined inflammatory process that can activate multitudes of other pathways seem primary disease function resulting in preterm birth
Etiology → Inflammation → Activation of multitudes of uterotonic events → Preterm birth
Connective tissue disease
CCL2, IFNG, IL4, IL15, IL10RA, IL1B, IL1R1, IL2RB, IL4R, IL6R, MMP2, NFKB1, NR3C1, POMC, SLC6A4, TIMP3, TNFR1, NFR2,
IFNG, IL6, IL8, IL10, IL15, IL1R1, IL1RN, IL2RB, MMP2, MMP3, MMP9, NFKB1, TIMP3, TLR4, TNF, TNFR1, TNFR2
This function also involves immune and inflammatory response genes. Matrix metalloproteinases can function in inflammation as well as collagen turnover function; e.g. involved in cervical ripening and membrane matrix degradation.
Skeletal and muscular disorder
CCL2, CTLA4, IFNG, IL4, IL15, IL10RA, IL1B, IL1R1, IL2RB, IL4R, IL6R, KL, MMP2, NFKB1, NOD2, NR3C1, POMC, SLC6A4, TNFR1, TNFR2, VEGFA
CD14, CTLA4, IFNG, IL2, IL6, IL8, IL10, IL15, IL1R1, IL1RN, IL2RB, MMP2, MMP3, MMP9, NFKB1, NFKBIB, NOD2, TLR4, TNF, TNFR1, TNFR2, TSHR
Most of these genes function in inflammatory regulation are related to rheumatic disorders, including matrix metalloproteinases that are also involved in cervical ripening and membrane matrix degradation.
Gene symbols and their names from Table 2 and 3
Chemokine (C-C motif) ligand 2
Cluster of differentiation 14
Collagen, type I, alpha 1
Collagen, type III, alpha 1
Collagen, type v, alpha 1
Collagen, type v, alpha 2
Corticotropin releasing hormone receptor 2
Cytotoxic T-Lymphocyte Antigen 4
Cytochrome P450, family 19, subfamily A, polypeptide 1
FA Factor 5
FA Factor 7
Insulin growth factor 1
IL-10 receptor antagonist
IL-1 receptor 1
IL-1 receptor accessory protein
IL-1 receptor antagonist
IL-2 receptor β
KLOTHO type-I membrane protein
Matrix metalloproteinase 1/collagensase 1
Matrix metalloproteinase 2/Glatinase A
Matrix metalloproteinase 3, stromelysin 1
Matrix metalloproteinase 8, neutrophil collagenase
matrix metalloproteinase 9/Gelatinase B
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta,
Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon
Nucleotide-binding oligomerization domain containing 2
Nuclear receptor subfamily 3
Phospholipase A2, group IVA
Tissue plasminogen activator
Prostaglandin E receptor 3
Prostaglandin-endoperoxide synthase 1
Prostaglandin-endoperoxide synthase 2
Sodium-dependent serotonin transporter
Tissue inhibitor of matrix metalloproteinase 3
Toll like receptor 2
Toll like receptor 4
Toll like receptor 7
Tumor necrosis factor
Tumor necrosis factor receptor 1
Tumor necrosis factor receptor 2
Triggering receptors on myeloid cell -1
Thyroid stimulating hormone receptor
Vascular endothelial growth factor A
In this study molecular groupings generated by IPA suggest a new way of examining SNP data to predict events involved in preterm birth. The networks that were found to be most significant (statistically) by IPA can be viewed as modules of interacting molecules that act in key physiological compartments involved in the pathophysiology of preterm birth. For each network, the IPA analysis generated new potential interacting biomarkers (partner molecules) that are highly interconnected with the variant genes we tested and provide a set of new testable hypotheses regarding predisposition to preterm birth.
Based on candidate gene studies, our group has already reported clear disparity in genetic associations with preterm birth in both maternal and fetal genome between African-Americans and Caucasians [10, 13, 14]. However, such studies provide little information on biological relevance other than the most simplistic relationships between single genes and PTB. The present study differs in that it provides a large set of potential risk factors that can ultimately predict risk based on gene-gene and gene-environment interactions based on documented biological pathways. The IPA approach provides more insight into potential functional roles of genes and more testable and biologically plausible hypotheses. Therefore, Based we can now argue with increased confidence that genetic variants linked with preterm birth participate in discrete pathways that define specific disease functions in each race.
This systems biology approach enables the identification of new pathways and genes. Understanding these disease functions and molecular networking can help categorize women into specific risk groups for targeted intervention. This approach introduces few assumptions concerning the types of pathophysiological processes that might be discerned. Accordingly, some "disease functions" identified by IPA as being associated with preterm birth may not have an obvious connection with parturition or preterm birth. However, the strength of Ingenuity is its broad and unbiased coverage of peer reviewed literature in cell biology, organ physiology, and pathology. Thus, the literature in diverse fields may be used to reveal clues to preterm birth, and the disease functions, it can provide substantial insight as long as caution is used in interpreting the disease functions output from IPA. We also emphasize that the primary data on which these analyses are based is small and will also require follow-up studies.
As with all studies connecting genetics, race, and PTB, our findings could be misused as an excuse for failing to rectify inequalities in social conditions and healthcare delivery that have well established links with PTB. However, genes act within environmental context, and we do not suggest race can be used as a proxy for genetic markers. For example, genes controlling inflammatory pathways are related to susceptibility to bacterial vaginosis, autoimmune disorders , and depression . If our data indicates that some mothers have vulnerabilities in these pathways, this implies a need for greater emphasis on preventive measures to improve the socio-environmental conditions that bring about these conditions.
In conclusion, we performed a network analysis to identify molecules and risk pathways that were not explicitly tested in our original genetic studies. These analyses produced statistical and visual evidence of racial disparity in key networks associated with other disease phenotypes that can provide important insights into the pathophysiology of preterm birth.
We gratefully acknowledge research support from the Perinatal Research Initiative funds from March of Dimes, USA (RM), Elsass foundation, Denmark (RM), Thrasher Research Funds (SJF), the National Institutes of Health, NIMH grant 5R21MH68513 (to BDP) and the NARSAD Young Investigator Award (BDP).
- Births: Preliminary Data for 2005. National Center for Health Statistics. 2006Google Scholar
- Hogan VK, Richardson JL, Ferre CD, Durant T, Boisseau M: A public health framework for addressing black and white disparities in preterm delivery. J Am Med Womens Assoc. 2001, 56 (4): 177-180.PubMedGoogle Scholar
- Kaufman JS, Cooper RS, McGee DL: Socioeconomic status and health in blacks and whites: the problem of residual confounding and the resiliency of race. Epidemiology. 1997, 8: 621-628. 10.1097/00001648-199710000-00002.PubMedGoogle Scholar
- Goldenberg RL, Cliver SP, Mulvihill FX, Hickey CA, Hoffman HJ, Klerman LV, Johnson MJ: Medical, psychosocial, and behavioral risk factors do not explain the increased risk for low birth weight among black women. Am J Obstet Gynecol. 1996, 175: 1317-1324. 10.1016/S0002-9378(96)70048-0.View ArticlePubMedGoogle Scholar
- Lu MC, Chen B: Racial and ethnic disparities in preterm birth: the role of stressful life events. Am J Obstet Gynecol. 2004, 191: 691-699. 10.1016/j.ajog.2004.04.018.View ArticlePubMedGoogle Scholar
- Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Pérez-Stable EJ, Sheppard D, Risch N: The importance of race and ethnic background in biomedical research and clinical practice. New Eng J Med. 2003, 348: 1170-5. 10.1056/NEJMsb025007.View ArticlePubMedGoogle Scholar
- Barnes KC: Genetic epidemiology of health disparities in allergy and clinical immunology. J Allergy Clin Immunol. 2006, 117: 243-254. 10.1016/j.jaci.2005.11.030.View ArticlePubMedGoogle Scholar
- DeFranco E, Teramo K, Muglia L: Genetic influences on preterm birth. Semin Reprod Med. 2007, 25: 40-51. 10.1055/s-2006-956774.View ArticlePubMedGoogle Scholar
- Kistka ZA, Palomar L, Lee KA, Boslaugh SE, Wangler MF, Cole FS, DeBaun MR, Muglia LJ: Racial disparity in the frequency of recurrence of preterm birth. Am J Obstet Gynecol. 2007, 196: 131.e1-6. 10.1016/j.ajog.2006.06.093.View ArticleGoogle Scholar
- Hao K, Wang X, Niu T, Xu X, Li A, Chang W, Wang L, Li G, Laird N, Xu X: A candidate gene association study on preterm delivery: application of high-throughput genotyping technology and advanced statistical methods. Hum Mol Genet. 2004, 13: 683-691. 10.1093/hmg/ddh091.View ArticlePubMedGoogle Scholar
- Fortunato SJ, Menon R, Velez DR, Thorsen P, Williams SM: Racial Disparity in Maternal-Fetal Genetic Epistasis in Spontaneous Preterm Birth. Am J Obstet Gynecol. 2008, 198 (6): e1-e9. 10.1016/j.ajog.2008.02.003.View ArticleGoogle Scholar
- Menon R, Velez DR, Thorsen P, Vogel I, Jacobsson B, Williams SM, Fortunato SJ: Ethnic characterization of candidate genes (Tumor Necrosis Factor-α and Receptors) for spontaneous preterm delivery. Hum Hered. 2006, 62: 107-118. 10.1159/000096301.View ArticlePubMedGoogle Scholar
- Velez DR, Menon R, Thorsen P, Jiang L, Simhan H, Morgan N, Fortunato SJ, Williams SM: Allelic and genotypic frequency variations in the IL-6 and IL-6R genes documents ethnic disparity in preterm birth. Ann Hum Genet. 2007, 71: 586-600. 10.1111/j.1469-1809.2007.00352.x.View ArticlePubMedGoogle Scholar
- Fortunato SJ, Lombardi SJ, Menon R: Racial disparity in membrane response to infectious stimuli. A possible explanation for observed differences in the incidence of prematurity. Am J Obstet Gynecol. 2004, 190: 1557-1563. 10.1016/j.ajog.2004.03.053.View ArticlePubMedGoogle Scholar
- Menon R, Merialdi M, Lombardi SJ, Fortunato SJ: Differences in the placental membrane cytokine response: a possible explanation for the racial disparity in preterm birth. Am J Reprod Immunol. 2006, 56: 112-118. 10.1111/j.1600-0897.2006.00394.x.View ArticlePubMedGoogle Scholar
- Velez DR, Fortunato SJ, Williams SM, Menon R: Preterm birth in African Americans is associated with infection and inflammatory response gene variants. Am J Obstet Gynecol. 2009, 200 (2): e1-e27. 10.1016/j.ajog.2008.08.051. Epub 2008 Nov 18.View ArticlePubMedGoogle Scholar
- Velez DR, Fortunato SJ, Williams SM, Menon R: Preterm birth in Caucasians is Associated with Coagulation Pathway Gene variants. PLoS ONE. 2008, 3: e3283-10.1371/journal.pone.0003283.PubMed CentralView ArticlePubMedGoogle Scholar
- Tang H, Quertermous T, Rodriguez B, Kardia SL, Zhu X, Brown A, Pankow JS, Province MA, Hunt SC, Boerwinkle E, Schork NJ, Risch NJ: Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet. 2005, 76: 268-275. 10.1086/427888.PubMed CentralView ArticlePubMedGoogle Scholar
- Liu XQ, Paterson AD, John EM, Knight JA: The role of self-defined race/ethnicity in population structure control. Ann Hum Genet. 2006, 70: 496-505. 10.1111/j.1469-1809.2005.00255.x.View ArticlePubMedGoogle Scholar
- Rosenberg NA, Pritchard JK, Weber JL, Cann HM, Kidd KK, Zhivotovsky LA, Feldman MW: Genetic structure of human populations. Science. 2002, 298: 2381-2385. 10.1126/science.1078311.View ArticlePubMedGoogle Scholar
- Liu K, Muse SV: PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics. 2005, 21: 2128-2129. 10.1093/bioinformatics/bti282.View ArticlePubMedGoogle Scholar
- Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, Miller-Graziano C, Moldawer LL, Mindrinos MN, Davis RW, Tompkins RG, Lowry SF: A network-based analysis of systemic inflammation in humans. Nature. 2005, 437: 1032-1037. 10.1038/nature03985.View ArticlePubMedGoogle Scholar
- Loza MJ, McCall CE, Li L, Isaacs WB, Xu J, Chang BL: Assembly of inflammation-related genes for pathway-focused genetic analysis. PLoS ONE. 2007, 2: e1035-10.1371/journal.pone.0001035.PubMed CentralView ArticlePubMedGoogle Scholar
- Kuijl C, Savage ND, Marsman M, Tuin AW, Janssen L, Egan DA, Ketema M, Nieuwendijk van den R, Eeden van den SJ, Geluk A, Poot A, Marel van der G, Beijersbergen RL, Overkleeft H, Ottenhoff TH, Neefjes J: Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature. 2007, 450: 725-730. 10.1038/nature06345.View ArticlePubMedGoogle Scholar
- Winn VD, Haimov-Kochman R, Paquet AC, Yang YJ, Madhusudhan MS, Gormley M, Feng KT, Bernlohr DA, McDonagh S, Pereira L, Sali A, Fisher SJ: Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology. 2007, 148: 1059-1079. 10.1210/en.2006-0683.View ArticlePubMedGoogle Scholar
- Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27: 24-31. 10.1016/j.it.2005.11.006.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.